Skip to main content

Traumatic Central Nervous System Injury

  • Chapter
CNS Neuroprotection

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 155))

  • 159 Accesses

Abstract

Traumatic injury to the central nervous system is an important public health problem. Severe head and spinal cord injuries are a major cause of disability and death, particularly among young adults. The medical sequelae of central nervous system injury are substantial, resulting in large demands upon the patient’s family, the health care system, and society in general. The National Head and Spinal Cord Injury Survey estimates the rate of occurrence of severe head injury at 200 per 100000 (Kraus et al. 1996). Motor vehicle accidents are the primary cause of both brain and spinal cord injury, and young healthy males are the primary victims.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alves WM, Eisenberg HM (1996) Head Injury Trials-Past and Present. In: Narayan RK, Wilberger JE Jr, Povlishock JT (eds) Neurotrauma. McGraw-Hill, New York, pp 946–967

    Google Scholar 

  • Bardt TF, Unterberg AW, Kiening KL, Schneider GH, Lanksch WR (1998) Multimodal cerebral monitoring in comatose head-injured patients. Acta Neurochir (Wien) 140:357–365

    Article  CAS  Google Scholar 

  • Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM, Hellenbrand KG, Ransohoff J, Hunt WE, Perot PL Jr et al. (1984) Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251:45–52

    Article  PubMed  CAS  Google Scholar 

  • Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo Summers L, Maroon J et al. (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405–1411

    Article  PubMed  CAS  Google Scholar 

  • Bracken MB, Shepard MJ, Holford TR, Leo Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W (1997) Administration of methylprednisolone for 24 or 48h or tirilazad mesylate for 48h in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277:1597–1604

    Article  PubMed  CAS  Google Scholar 

  • Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R et al. (1992) Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90min. Stroke 23:632–640

    Article  PubMed  CAS  Google Scholar 

  • Bullock R, Chesnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK, Newell DW, Pitts LH, Rosner MJ, Wilberger JW (1996) Guidelines for the management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med 3:109–127

    Article  PubMed  CAS  Google Scholar 

  • Bullock R, Zauner A, Woodward JJ, Myseros J, Choi SC, Ward JD, Marmarou A, Young HF (1998) Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 89:507–518

    Article  PubMed  CAS  Google Scholar 

  • Chesnut RM, Marshall SB, Piek J, Blunt BA, Klauber MR, Marshall LF (1993) Early and late systemic hypotension as a frequent and fundamental source of cerebral ischemia following severe brain injury in the Traumatic Coma Data Bank. Acta Neurochir Suppl (Wien) 59:121–125

    CAS  Google Scholar 

  • Chesnut RM (1997) Avoidance of hypotension: conditio sine qua non of successful severe head-injury management. J Trauma 42:S4–S9

    Article  Google Scholar 

  • Choi SC, Ward JD, Becker DP (1983) Chart for outcome prediction in severe head injury. J Neurosurg 59:294–297

    Article  PubMed  CAS  Google Scholar 

  • Choi SC, Narayan RK, Anderson RL, Ward JD (1988) Enhanced specificity of prognosis in severe head injury. J Neurosurg 69:381–385

    Article  PubMed  CAS  Google Scholar 

  • Choi SC, Germanson TP, Barnes TY (1995) A simple measure in defining optimal strata in clinical trials. Control Clin Trials 16:164–171

    Article  PubMed  CAS  Google Scholar 

  • Choi SC, Barnes TY (1996) Predicting Outcome in the Head Injured Patient. In: Narayan RK, Wilberger JE Jr, Povlishock JT (eds) Neurotrauma. McGraw-Hill, New York, pp 779–792

    Google Scholar 

  • Choi SC, Marmarou A, Bullock R, Nichols J, Wei X, Pitts L, The American Brain Injury Consortium Study Group (1998) Primary endpoints in phase III clinical trials of severe head trauma: DRS versus GOS. J Neurotrauma 15:771–776

    Article  PubMed  CAS  Google Scholar 

  • Clifton GL, Hayes RL, Levin HS, Michel ME, Choi SC (1992) Outcome measures for clinical trials involving traumatically brain-injured patients: report of a conference. Neurosurgery 31:975–978

    Article  PubMed  CAS  Google Scholar 

  • Doppenberg EM, Bullock R (1997) Clinical neuro-protection trials in severe traumatic brain injury: lessons from previous studies. J Neurotrauma 14:71–80

    Article  PubMed  CAS  Google Scholar 

  • Fleishaker JC, Pearson LK, Peters GR (1998) Induction of tirilazad clearance by Phenytoin. Biopharm Drug Dispos 19:91–96

    Article  PubMed  CAS  Google Scholar 

  • Gaetani P, Tancioni F, Tartara F, Carnevale L, Brambilla G, Mille T, Rodriguez y Baena R (1995) Prognostic value of the amount of posttraumatic subarachnoid haemorrhage in a six month follow up period. J Neurol Neurosurg Psychiatry 59:635–637

    Article  PubMed  CAS  Google Scholar 

  • Gennarelli TA, Spielman GM, Langfitt TW, Gildenberg PL, Harrington T, Jane JA, Marshall LF, Miller JD, Pitts LH (1982) Influence of the type of intracranial lesion on outcome from severe head injury. J Neurosurg 56:26–32

    Article  PubMed  CAS  Google Scholar 

  • Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH (1995) Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med 23:560–567

    Article  PubMed  CAS  Google Scholar 

  • Haley EC Jr, Kassell NF, Apperson Hansen C, Maile MH, Alves WM (1997) A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467–474

    Article  PubMed  CAS  Google Scholar 

  • Hall ED (1992) The neuroprotective pharmacology of methylprednisolone. J Neurosurg 76:13–22

    Article  PubMed  CAS  Google Scholar 

  • Hamilton BB, Granger CV, Sherwin FS (1987) A uniform national data system for medical rehabilitation. In: Fuhrer MJ (ed) Rehabilitation Outcomes: Analysis and Measurement. Brooks, Baltimore, pp 137–147

    Google Scholar 

  • Hayes RL, Dixon CE (1994) Neurochemical changes in mild head injury. Semin Neurol 14:25–31

    Article  PubMed  CAS  Google Scholar 

  • Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480–484

    Article  PubMed  CAS  Google Scholar 

  • Jennett B, Snoek J, Bond MR, Brooks N (1981) Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry 44:285–293

    Article  PubMed  CAS  Google Scholar 

  • Kassell NF, Haley EC Jr, Apperson Hansen C, Alves WM (1996) Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221–228

    Article  PubMed  CAS  Google Scholar 

  • Kraus JF, McArthur DL, Silverman TA, Jayaraman M (1996) Epidemiology of Brain Injury. In: Narayan RK, Wilberger JE Jr, Povlishock JT (eds) Neurotrauma, vol 1. McGraw-Hill, New York, pp 13–30

    Google Scholar 

  • Levin HS, High WM, Goethe KE, Sisson RA, Overall JE, Rhoades HM, Eisenberg HM, Kalisky Z, Gary HE (1987) The neurobehavioural rating scale: assessment of the behavioural sequelae of head injury by the clinician. J Neurol Neurosurg Psychiatry 50:183–193

    Article  PubMed  CAS  Google Scholar 

  • Maas AI, Dearden M, Teasdale GM, Braakman R, Cohadon F, Iannotti F, Karimi A, Lapierre F, Murray G, Ohman J, Persson L, Servadei F, Stocchetti N, Unterberg A (1997) EBIC-guidelines for management of severe head injury in adults. European Brain Injury Consortium. Acta Neurochir (Wien) 139:286–294

    Article  CAS  Google Scholar 

  • Marmarou A (1996) Conduct of head injury trials in the United States: the American Brain Injury Consortium (ABIC). Acta Neurochir Suppl (Wien) 66:118–121

    CAS  Google Scholar 

  • Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L, The American Brain Injury Consortium Study Group (1999) Effects of the bradykinin antagonist Bradycor (Deltibant, CP-1027) in severe brain injury: results of a multi-center, randomized, placebo-controlled trial. In Press

    Google Scholar 

  • Marshall LF, Becker DP, Bowers SA, Cayard C, Eisenberg H, Gross CR, Grossman RG, Jane JA, Kunitz SC, Rimel R, Tabaddor K, Warren J (1983) The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results. J Neurosurg 59:276–284

    Article  PubMed  CAS  Google Scholar 

  • Marshall LF, Maas AI, Marshall SB, Bricolo A, Fearnside M, Iannotti F, Klauber MR, Lagarrigue J, Lobato R, Persson L, Pickard JD, Piek J, Servadei F, Wellis GN, Morris GF, Means ED, Musch B (1998) A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg 89:519–525

    Article  PubMed  CAS  Google Scholar 

  • Mcintosh TK, Juhler M, Wieloch T (1998) Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998. J Neurotrauma 15:731–769

    Article  PubMed  CAS  Google Scholar 

  • NINDS rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587

    Article  Google Scholar 

  • Rappaport M, Hall KM, Hopkins K, Belleza T, Cope DN (1982) Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil 63:118–123

    PubMed  CAS  Google Scholar 

  • Sandage BW (1998) Balancing phase II and III efficacy trials. Drug Inf J 32:977–980

    Google Scholar 

  • Scheibel RS, Levin HS, Clifton GL (1998) Completion rates and feasibility of outcome measures: experience in a multicenter trial of systemic hypothermia for severe head injury. J Neurotrauma 15:685–692

    Article  PubMed  CAS  Google Scholar 

  • Teasdale GM, Braakman R, Cohadon F, Dearden M, Iannotti F, Karimi A, Lapierre F, Maas A, Murray G, Ohman J, Persson L, Servadei F, Stocchetti N, Trojanowski T, Unterberg A (1997) The European Brain Injury Consortium. Nemo solus satis sapit: nobody knows enough alone. Acta Neurochir (Wien) 139:797–803

    Article  CAS  Google Scholar 

  • Teasdale GM, Pettigrew L, Wilson JT, Murray G, Jennett B (1998) Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma 15:587–597

    Article  PubMed  CAS  Google Scholar 

  • Teasdale GM, Graham DI (1998) Craniocerebral trauma: protection and retrieval of the neuronal population after injury. Neurosurgery 43:723–737

    Article  PubMed  CAS  Google Scholar 

  • Toulmond S, Serrano A, Benavides J, Scatton B (1993) Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window. Brain Res 620:32–41

    Article  PubMed  CAS  Google Scholar 

  • Wichman A, Sandler AL (1997) Research involving critically ill subjects in emergency circumstances: new regulations, new challenges. Neurology 48:1151–1155

    Article  PubMed  CAS  Google Scholar 

  • Wilson JT, Pettigrew L, Teasdale GM (1998) Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15:573–585

    Article  PubMed  CAS  Google Scholar 

  • Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW (1996) Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 276:538–543

    Article  PubMed  CAS  Google Scholar 

  • Zivin JA (1998) Factors determining the therapeutic window for stroke. Neurology 50:599–603

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Poole, R.M. (2002). Traumatic Central Nervous System Injury. In: Marcoux, F.W., Choi, D.W. (eds) CNS Neuroprotection. Handbook of Experimental Pharmacology, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06274-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06274-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07625-1

  • Online ISBN: 978-3-662-06274-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics